Biotech Acquisition Co - Warrants (30/11/2027)'s total current liabilities is $3.5M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total current liabilities for BIOTW is $3.5M as of September 2022. That compares with $360K in the prior-year period — up 881.1% year over year. Investors often review this figure alongside Biotech Acquisition Co - Warrants (30/11/2027)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, BIOTW's total current liabilities moved from $360K to $3.5M — a 881.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biotech Acquisition Co - Warrants (30/11/2027)'s operating scale or balance-sheet position.
A total current liabilities figure of $3.5M for BIOTW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting BIOTW's total current liabilities ($3.5M), review year-over-year change from $360K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.